Fig. 2.
Fig. 2. Median PAI-1 levels in patients with CR, median PAI-1 levels in patients surviving to day +100 versus NR across DF therapy (n = 43) versus nonsurvivors (n = 43).

Median PAI-1 levels in patients with CR, median PAI-1 levels in patients surviving to day +100 versus NR across DF therapy (n = 43) versus nonsurvivors (n = 43).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal